2009Sichuan Medical JournalRequires access

The application of metformin combined with pioglitazone in treatment with obesity type 2 diabetes patients

LI Ron

Open publisher page 0 citations

Abstract

Objective To observe the clinical effects of metformin combined with pioglitazone in treatment with obesity type 2 diabetes(T2DM)patients.Methods From January 2008 to January 2009,84 cases of obesity T2DM patients were randomly classified into two groups,which observation group were treated with metformin combined with pioglitazone and control group were treated with metformin.The blood sugar,insulin and blood fat were observed.Results Compared with pre-treatment,the FPG,2hPG,FINS and P2INS were significantly increased(P0.05)after treatment in two groups.Moreover,the FPG,2hPG,FINS and P2INS in observation group were significantly lower than those in control group(P0.05).There were no significantly differences in TC,TG,HDL-C and LDL-C between pre-treatment and pro-treatment(P0.05).Conclusion metformin combined with pioglitazone can decrease blood sugar and insulin levels,which is a idea method in treatment with obesity T2DM patients.

About this research paper

What this paper is about

Objective To observe the clinical effects of metformin combined with pioglitazone in treatment with obesity type 2 diabetes(T2DM)patients.Methods From January 2008 to January 2009,84 cases of obesity T2DM patients were randomly classified into two groups,which observation group were treated with metformin combined with pioglitazone and control group were treated with metformin.The blood sugar,insulin and blood fat were observed.Results Compared with pre-treatment,the FPG,2hPG,FINS and P2INS were significantly increased(P0.05)after treatment in two groups.Moreover,the FPG,2hPG,FINS and P2INS in observation group were significantly lower than those in control group(P0.05).There were no significantly differences in TC,TG,HDL-C and LDL-C between pre-treatment and pro-treatment(P0.05).Conclusion metformin combined with pioglitazone can decrease blood sugar and insulin levels,which is a idea method in treatment with obesity T2DM patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effects of metformin combined with pioglitazone in treatment with obesity type 2 diabetes(T2DM)patients.Methods From January 2008 to January 2009,84 cases of obesity T2DM patients were randomly classified into two groups,which observation group were treated with metformin combined with pioglitazone and control group were treated with metformin.The blood sugar,insulin and blood fat were observed.Results Compared with pre-treatment,the FPG,2hPG,FINS and P2INS were significantly increased(P0.05)after treatment in two groups.Moreover,the FPG,2hPG,FINS and P2INS in observation group were significantly lower than those in control group(P0.05).There were no significantly differences in TC,TG,HDL-C and LDL-C between pre-treatment and pro-treatment(P0.05).Conclusion metformin combined with pioglitazone can decrease blood sugar and insulin levels,which is a idea method in treatment with obesity T2DM patients.

Key concepts: Pioglitazone, Medicine, Metformin, Internal medicine, Type 2 diabetes, Blood sugar, Obesity, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
The application of metformin combined with pioglitazone in treatment with obesity type 2 diabetes patients — Research Paper | ScholarLens